South Carolinamed spa & injectable regulations
What’s changing for med spas and injectors in South Carolina — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in South Carolina. Med Spa Radar monitors it all and tells you, in plain language, what changed and what to do.
Latest South Carolina changes
- MONITORLegiScan2023-03-07
SC H4084: Dental administration of neuromodulators
SC bill proposed for dental administration of neuromodulators.
Federal changes that apply in South Carolina
FDA and Federal Register actions are nationwide — they govern South Carolina practices too.
- CRITICALFEDERALFDA Enforcement2025-09-10
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
FDA recalls compounded GLP-1 product for being subpotent.
- CRITICALFEDERALFDA Enforcement2025-08-13
FDA recall (Class II): Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
FDA recalls compounded GLP-1 product; check your stock now!
- CRITICALFEDERALFDA Enforcement2026-01-07
FDA recall (Class II): Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
FDA recalls Wegovy; med spas must check supplies!
- CRITICALFEDERALFDA Enforcement2026-03-11
FDA recall (Class II): Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061,…
FDA recalls Semaglutide for sterility issues—act now!
- CRITICALFEDERALFDA Enforcement2026-01-07
FDA recall (Class II): Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 B…
FDA recalls Wegovy due to safety concerns; med spas must act.
- CRITICALFEDERALFDA Enforcement2025-07-02
FDA recall (Class II): Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80…
FDA recalls GLP-1 product over sterility issues.
What we monitor in South Carolina
- South Carolina legislature — bills on injectables, GLP-1s & scope of practice
- South Carolina Board of Nursing — injector scope & delegation
- South Carolina Medical Board — physician supervision & ownership rules
- South Carolina Board of Pharmacy — compounding & 503A/503B
- U.S. FDA — enforcement, warning letters, recalls, shortages
- Federal Register — new rules on compounding & aesthetics
South Carolina med spa compliance — FAQ
- Where do South Carolina med spa and injectable regulations come from?
- South Carolina med spas and injectors are governed by a mix of state and federal authorities — the South Carolina legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. Med Spa Radar monitors all of them for South Carolina and flags what changed in plain language.
- Does the FDA's GLP-1 compounding guidance apply in South Carolina?
- Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in South Carolina. We track those federal changes alongside any South Carolina-specific rules so you see the full picture for your practice.
- How do I keep up with South Carolina regulatory changes?
- Med Spa Radar sends a free weekly Brief on what changed across South Carolina, the FDA, and the Federal Register. Members get the exact "what to do" for their states in real time. It's regulatory monitoring, not legal advice.
Never miss a South Carolina change
Get the free weekly Brief on what changed across South Carolina, the FDA, and the Federal Register. Members get the exact what-to-do, in real time, for their states.
Get the free Brief →← All states · Regulatory monitoring, not legal advice.